Published in Nucleic Acids Res on March 23, 2015
Applications of CRISPR technologies in research and beyond. Nat Biotechnol (2016) 1.34
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes. Nat Biotechnol (2016) 1.03
Harnessing Type I and Type III CRISPR-Cas systems for genome editing. Nucleic Acids Res (2015) 0.91
Targeted mutagenesis in chicken using CRISPR/Cas9 system. Sci Rep (2016) 0.86
Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther (2016) 0.84
One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system. Sci Rep (2016) 0.83
CRISPR guide RNA design for research applications. FEBS J (2016) 0.83
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity. Vaccines (Basel) (2015) 0.81
Future of breeding by genome editing is in the hands of regulators. GM Crops Food (2015) 0.81
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat Commun (2017) 0.80
Parallel reverse genetic screening in mutant human cells using transcriptomics. Mol Syst Biol (2016) 0.78
Diversity of CRISPR-Cas immune systems and molecular machines. Genome Biol (2015) 0.78
Targeting cellular mRNAs translation by CRISPR-Cas9. Sci Rep (2016) 0.78
Biochemical Methods To Investigate lncRNA and the Influence of lncRNA:Protein Complexes on Chromatin. Biochemistry (2016) 0.77
A decade of discovery: CRISPR functions and applications. Nat Microbiol (2017) 0.77
Targeting Non-Coding RNAs in Plants with the CRISPR-Cas Technology is a Challenge yet Worth Accepting. Front Plant Sci (2015) 0.77
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget (2016) 0.75
Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J (2016) 0.75
Targeted CRISPR disruption reveals a role for RNase MRP RNA in human preribosomal RNA processing. Genes Dev (2017) 0.75
Metabolic engineering of cottonseed oil biosynthesis pathway via RNA interference. Sci Rep (2016) 0.75
GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells. Sci Rep (2016) 0.75
Accelerating the search for the missing proteins in the human proteome. Nat Commun (2017) 0.75
Building a Genetic Manipulation Tool Box for Orchid Biology: Identification of Constitutive Promoters and Application of CRISPR/Cas9 in the Orchid, Dendrobium officinale. Front Plant Sci (2017) 0.75
Perspectives on avian stem cells for poultry breeding. Anim Sci J (2016) 0.75
The adaptor protein Disabled-2: new insights into platelet biology and integrin signaling. Thromb J (2016) 0.75
Efficient generation of mutations mediated by CRISPR/Cas9 in the hairy root transformation system of Brassica carinata. PLoS One (2017) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev (2001) 26.16
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
Small CRISPR RNAs guide antiviral defense in prokaryotes. Science (2008) 17.79
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature (2011) 17.38
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72
Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol (2003) 16.63
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51
RNA-programmed genome editing in human cells. Elife (2013) 14.82
Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol (2002) 14.67
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature (2010) 14.21
Rational siRNA design for RNA interference. Nat Biotechnol (2004) 14.16
Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol (2007) 13.67
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science (2008) 11.82
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct (2006) 11.31
RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell (2009) 11.12
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol (2005) 11.05
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature (2006) 10.95
Genetic screens in human cells using the CRISPR-Cas9 system. Science (2013) 10.75
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev (2002) 10.71
Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology (2009) 10.67
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res (2011) 10.43
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (2005) 10.20
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (2005) 9.83
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol (2014) 9.18
Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93
A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67
Circular RNAs are a large class of animal RNAs with regulatory potency. Nature (2013) 8.54
The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell (1992) 8.05
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med (2003) 7.37
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med (2005) 7.18
Ancestral polyploidy in seed plants and angiosperms. Nature (2011) 7.00
Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol (2007) 7.00
3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods (2006) 6.96
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol (2014) 6.85
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19
Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature (2008) 5.78
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol (2014) 5.71
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature (2014) 5.70
Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol (2000) 5.46
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Playing the end game: DNA double-strand break repair pathway choice. Mol Cell (2012) 5.42
Cancer proliferation gene discovery through functional genomics. Science (2008) 5.41
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol (2005) 5.37
Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell (2014) 5.26
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature (2014) 5.19
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science (2014) 5.13
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature (2014) 4.95
Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods (2009) 4.76
Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA (2006) 4.72
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol (2013) 4.72
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature (2007) 4.70
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol (2014) 4.41
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell (2013) 3.97
Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol (2013) 3.80
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Nature (2014) 3.80
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol (2014) 3.66
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol (2014) 3.48
A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol (2006) 3.46
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell (2005) 3.35
Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods (2014) 3.34
Saturation editing of genomic regions by multiplex homology-directed repair. Nature (2014) 3.30
Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell (2013) 3.30
Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther (2005) 3.28
CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature (2014) 3.28
High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet (2006) 3.22
Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew. Nat Biotechnol (2014) 3.22
Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell (2014) 3.16
The art and design of genetic screens: RNA interference. Nat Rev Genet (2008) 3.11
RNA-based therapeutics: current progress and future prospects. Chem Biol (2012) 3.01
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science (2014) 2.93
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat Chem Biol (2006) 2.91
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell (2014) 2.87
Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol Cell (2011) 2.82
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res (2014) 2.59
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell (2014) 2.57
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci U S A (2014) 2.32
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25